FDA draft guidance tightens CGT bioreactor audit trails, requiring CSV and ALCOA+ compliance before U.S. shipment. See what suppliers, buyers, and QA teams must do now.

ECHA adds 12 SVHCs, directly impacting SUT exports to the EU. Learn how SCIP notification, REACH updates, and supplier readiness could affect customs, compliance, and supply continuity.

Single-use Bioreactors face new FDA import file rules from Sept. 1, 2026. Learn the EU Agent declaration and CSV package requirements to avoid delays and stay compliant.

Single-use bioprocessing cost depends on more than bag price. Learn the real commercial-scale drivers—labor, yield, validation, supply risk, and ROI—to make smarter sourcing decisions.

EMA tightens EU import rules for bioprocess equipment, requiring CSV packages and EU Authorized Representative declarations. Learn who is affected and how to prepare before Oct 1, 2026.

FDA Sets New Import Filing Rules for Single-Use Bioreactors: learn how the 2026 FDA update impacts CSV documentation, U.S. Agent declarations, import clearance, and GMP traceability.

CHO cell culture bioreactors for monoclonal antibody production: learn how to compare oxygen transfer, control, single-use vs. stainless, and scale-up fit to improve yield and reduce risk.

EMA Sets New Import Rule for Single-Use Bioreactors: learn how the 2026 EU update impacts EU-MDR declarations, biocompatibility files, customs clearance, and supplier compliance.